China rolls out new Covid cure

china rolls out new covid cure

Sumary of China rolls out new Covid cure:

  • XINHUA PHOTO BEIJING: Chinese researchers are rolling out a number of remedies specific for Covid-19 treatment as the world races into the third phase of the anti-epidemic fight characterized by a combination of accessible vaccines and drugs.
  • Among drug producers in China, a neutralizing monoclonal antibody combination therapy is expected to become the first in the country to get approval for market use in December.
  • The combination therapy is codeveloped by Tsinghua University, the Third People’s Hospital of Shenzhen and Brii Biosciences, a company that has dual headquarters in China and the United States.
  • The goal of our research is to pick out the strongest ones that can be used as antibody drugs to treat infected patients,” Zhang Linqi, a professor at the School of Medicine at Tsinghua University, was quoted as saying by Science and Technology Daily on Monday.
  • Tao Lina, an expert on immunology, told the Global Times that the theory of neutralizing antibody-based therapies is to use the antibody in the medicines to neutralize the virus.
  • } Brii Biosciences announced in late August that its SARS-CoV-2 therapy BRII-196/BRII-198 demonstrated a statistically significant reduction of 78 percent in the hospitalization and death in phase 3 clinical trials conducted in the United States, Brazil, South Africa, Mexico, Argentina and the Philippines.
  • It is most likely for the therapy to be authorized for emergency use in the United States, the Science and Technology Daily report said, citing a source from Brii.
  • The therapy has also proven effective against major coronavirus variants including the Delta, Lambda and MU variants, the Beijing Daily reported.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.